Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females.

about

Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.Trial watch: DNA-based vaccines for oncological indications

P2860

Q50060583-1361EBF1-B339-4292-9A94-8490D76A2E6E Q56893452-4180AD74-36A8-4C4C-A253-45DEA4417481

P2860

Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females.

Item

http://www.wikidata.org/entity/Q50788444

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Reactogenicity of Cervarix and ...... healthy UK adolescent females.

@en

Reactogenicity of Cervarix and Gardasil human papillomavirus

@nl

type

Item

label

Reactogenicity of Cervarix and ...... healthy UK adolescent females.

@en

Reactogenicity of Cervarix and Gardasil human papillomavirus

@nl

prefLabel

Reactogenicity of Cervarix and ...... healthy UK adolescent females.

@en

Reactogenicity of Cervarix and Gardasil human papillomavirus

@nl

P1476

Reactogenicity of Cervarix and ...... healthy UK adolescent females.

@en

P2093

Elizabeth Miller

http://www.w3.org/2001/XMLSchema#string

Jo Southern

http://www.w3.org/2001/XMLSchema#string

Nick Andrews

http://www.w3.org/2001/XMLSchema#string

Tao Haskins-Coulter

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial

Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience.

An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.

Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination.

Vaccination with a human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in Korean girls aged 10-14 years

Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years.

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only.

A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls.

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2016.1277846

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28319456

http://www.w3.org/2001/XMLSchema#string

P921

teenager

P932

5489300

http://www.w3.org/2001/XMLSchema#string

Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females.

about

P2860

P2860

Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932